The visit of Industries Minister KT Rama Rao to the United States has aided in attracting large investments to Telangana.
Slayback Pharma, based in New Jersey, said that it will invest $20 million in Hyderabad over the next three years to expand its operations. In Hyderabad, the business will build a cGMP lab and a production facility as part of these objectives.
During the previous five years, the corporation has already invested roughly USD 30 million.
Slayback Pharma is a pharmaceutical company that specialises in the creation of difficult generic and speciality medications.
